IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Consonance Capital Management LP

Q3 2018 Holdings

Filed 2018-11-14 | 29 holdings | $131.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corcept Therapeutics Inc(CORT)COM218352102$70.6M5,038,87453.7%
Adma Biologics Inc(ADMA)COM000899104$28.2M4,539,29521.4%
Catalyst Pharmaceuticals Inc(CPRX)COM14888U101$22.8M6,044,71917.4%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$8.1M142,9436.1%
Pacira Pharmaceuticals Inc(PCRX)COM695127100$179.5K3,652,1340.1%
Retrophin IncCOM761299106$112.5K3,914,1820.1%
United Therapeutics Corp del(UTHR)COM91307C102$110.3K862,2950.1%
Puma Biotechnology Inc(PBYI)COM74587V107$105.6K2,303,4550.1%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$102.0K4,443,7590.1%
Spectrum Pharmaceuticals IncCOM84763A108$97.9K5,829,8780.1%
Nevro Corp(NVROEUR)COM64157F103$82.4K1,446,3330.1%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$82.2K4,827,0780.1%
Amarin Corp PLCSPONS ADR NEW023111206$80.8K4,968,6630.1%
Nuvasive Inc(NUVAGBP)COM670704105$77.3K1,089,5230.1%
Myriad Genetics Inc(MYGN)COM62855J104$75.7K1,646,3300.1%
Pacific Biosciences Calif in(PACB)COM69404D108$73.1K13,512,9580.1%
Luminex Corp delCOM55027E102$71.8K2,369,0080.1%
Urogen Pharma LTD(URGN)COMM96088105$71.6K1,515,4220.1%
Exelixis Inc(EXEL)COM30161Q104$68.7K3,879,0500.1%
Vericel Corp(VCEL)COM92346J108$59.0K4,168,0920.0%
Stemline Therapeutics IncCOM85858C107$45.6K2,747,1980.0%
Oxford Immunotec Global PLCORD SHSG6855A103$39.8K2,449,1840.0%
Uniqure NV(QURE)SHSN90064101$38.0K1,045,0650.0%
Verastem IncCOM92337C104$37.4K5,154,2240.0%
Savara Inc(SVRA)COM805111101$34.5K3,093,6900.0%
RA Pharmaceuticals IncCOM74933V108$26.3K1,454,7610.0%
Theravance Biopharma Inc(TBPH)COMG8807B106$23.9K731,9090.0%
Sesen BIO IncCOM817763105$16.2K7,523,2960.0%
Innoviva Inc(INVA)COM45781M101$15.3K1,002,6750.0%